HYPERION DEFI, INC. (HYPD) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value |
| Current obligations | 5.51M USD | Liabilities, Current |
| Cash and equivalents | 9.64M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory · excluded from quick assets | (m) | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $5.51M | $9.64M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $4.47M | $7.38M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $2.70M | $6.44M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $4.04M | $8.22M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $10.31M | $7.53M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $15.10M | $3.93M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $16.05M | $2.12M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $15.78M | $7.19M | (m) | (m) | $2.97M | (m) |
| 2024-06-30 | (m) | $15.85M | $2.30M | (m) | (m) | $3.05M | (m) |
| 2024-03-31 | (m) | $16.46M | $7.98M | (m) | (m) | $3.51M | (m) |
| 2023-12-31 | (m) | $9.53M | $14.85M | (m) | (m) | $109.80K | (m) |
| 2023-09-30 | (m) | $6.55M | $20.70M | (m) | (m) | $50.30K | (m) |
| 2023-06-30 | (m) | $4.06M | $17.47M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $4.90M | $18.47M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $4.51M | $22.86M | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $11.02M | $17.40M | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $11.98M | $21.51M | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $10.38M | $26.72M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $11.17M | $19.46M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $20.72M | $13.50M | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $14.56M | $27.18M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $16.37M | $24.91M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $18.20M | $28.37M | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $6.74M | $22.86M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $2.76M | $10.19M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $2.54M | $13.66M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $2.91M | $14.15M | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $2.43M | $18.30M | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $2.37M | $9.24M | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $2.52M | $14.32M | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $3.10M | $19.73M | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $1.73M | $21.04M | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $1.28M | $24.56M | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $1.12M | $27.60M | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $552.65K | $5.25M | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | $7.41M | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | $1.46M | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | $2.51M | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $423.73K | $3.39M | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $2.49M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |